Randomized controlled trialHuman

Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial

American heart journal, 2013 Nov. Marso SP, Poulter NR, Nissen SE and 11 others.

Study type

Randomized controlled trial

Subjects

Human participants (PubMed MeSH: Humans)

Journal

American heart journal

Published

2013 Nov

PubMed

PMID 24176437 ↗

DOI

10.1016/j.ahj.2013.07.012 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Liraglutide →

Indexed under

MeSH terms assigned by the National Library of Medicine.

AgedCardiovascular DiseasesDiabetes Mellitus, Type 2Double-Blind MethodFemaleGlucagon-Like Peptide 1HumansHypoglycemic AgentsLiraglutideMaleMiddle AgedResearch Design

Other papers on Liraglutide

Randomized controlled trial · 2016

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Randomized controlled trial · 2015

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page